Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2014-04-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Hub and Satellite" Heart Failure Provider's Network Study
NCT01246050
Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics
NCT02052804
Feasibility and Acceptability of Three Component Intervention for the Heart Failure Care for Rural Dwelling Participants
NCT07103239
Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease
NCT03551756
IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
NCT00303979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Guideline based care
Prior to discharge. Survey data will include descriptive characteristics, depression, heart failure knowledge. After patient education is complete prior to discharge patients will complete a readiness for discharge scale and heart failure self-care survey.
Phone call 48 hours after discharge. Discharge instructions will be reinforced.
Phone call 7 days after discharge. Survey data will include self management, complications, and satisfaction care.
Secondary data 30 days post discharge. The hospital electronic medical record system will be queried to determine if the patient has been readmitted within 30 days of discharge for heart failure or non-heart failure causes.
Guideline based care
Patient education using guideline based teaching guides
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Guideline based care
Patient education using guideline based teaching guides
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 20
* Cognitively intact
* English speaking
* Plan for discharge to home, assisted living or intermediate care
Exclusion Criteria
* Patients enrolled in another research study to test interventions to improve heart failure knowledge, self-management or reduce readmission to the hospital within 30 days post discharge
* Patients that are cognitively impaired
* Patients that are transferred to another unit in the hospital, and will be discharged from that unit
* Patients who undergo or have a planned surgical intervention during their hospital stay
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, Baltimore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robin P Newhouse, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Riverside Shore Memorial Hospital
Nassawadox, Virginia, United States
Riverside Tappahannock Hospital
Tappahannock, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00055798
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.